S. Korea begins using remdesivir for critically ill COVID-19 patients

Published by : ARIRANG NEWS
질본 "렘데시비르 오늘부터 공급,... 길리어드사와 무상공급 계약"

From today, patients in South Korea who are critically ill with COVID-19 will be administered remdesivir as part of their treatment.
The Korea Centers for Diseases Control said Wednesday that the experimental drug,... conventionally used to treat Ebola, will now be available for badly ill COVID-19 patients.
Patients that will be prioritized for remdesivir are those with pneumonia and those in need oxygen.
Details regarding the amount imported and the price were not disclosed as part of the deal between the drugmaker Gilead Sciences and the Korea Centers for Diseases Control.
In a U.S.-government-led study,... remdesivir was found to have shortened recovery times by 31 percent and so far it's the only drug authorized by federal regulators to treat COVID-19 patients.

#SouthKorea #remdesivir #COVID19

📣 Arirang News(Facebook) : https://www.facebook.com/arirangtvnews
📣 Arirang News(Twitter) : https://twitter.com/arirangtvnews
📣 News Center(YouTube) : https://www.youtube.com/c/NEWSCENTER_ARIRANGTV
cached video

arirang tv south korea korean SouthKorea ArirangNews news Seoul arirangtv 아리랑tv 아리랑뉴스 뉴스 북한 northkorea 대한민국 미국 U.S. policy politics 질병관리본부 정부 길리어드사 무상 계약 렘데시비르 협상 공급 코로나19 세계보건기구 국제 사망 죽음 신종코로나 바이러스 폐렴 우한 중국 전염병 질병 정치 정책 방역 감염 COVID19 WHO novel coronavirus pandemic confirmed World Health Organization Wuhan China worldwide epidemic death quarantine report briefing measure inspection Remdesivir treatment supply import negotiation government Prevention Gilead contract